SM_190b: Calcium / Parathyroid / Bone Flashcards

1
Q

Describe Ca homeostasis and actions of PTH

A

Ca homeostasis and actions of PTH

  • Kidney -> Ca, which inhibits PTH
  • Bone -> PO4
  • Negative feedback from Ca and 1,25 Vitamin D on PTH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe etiologies of hypercalcemia

A

Hypercalcemia

  • Vitaminosis D and A
  • Immobility
  • Thyrotoxicosis
  • Adrenal insufficiency
  • Milk alkali syndrome, multiple myeloma
  • Infections: granulomatous (TB, fungal)
  • Neoplasms
  • Sarcoidosis
  • Thiazides and other meds
  • Rhabdomyolysis / renal FHH
  • AIDS
  • PTH, paraproteinemias

VITAMIN TRAP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PTH dependent hypercalcemia is commonly caused by ___ and ___

A

PTH dependent hypercalcemia is commonly caused by primary hyperparathyroidism and familial hypocalciuric hypercalcemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Non-PTH dependent hypercalcemia is commonly caused by ____

A

Non-PTH dependent hypercalcemia is commonly caused by malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hypercalcemia presents with ___, ___, ___, and ___

A

Hypercalcemia presents with stones, bones, groans, and psychogenic overtones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe clinical features of hypercalcemia

A

Hypercalcemia clinical features

  • Nephrolithiasis / nephrocalcinosis
  • Arthralgias, myalgias, weakness
  • Abdominal pain, constipation, nausea / vomiting
  • Neurologic impairment: mild to severe
  • Polyuria
  • Shortened QT interval
  • Increased symptoms with higher Ca levels (such as Ca ≥ 12 mg/dL)

(stones, bones, groans, and psychogenic overtones)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hypercalcemia therapy first line is ____

A

Hypercalcemia therapy first line is to stop any offending medications / supplements

  • Hydration
  • Loop diuretics (furosemide) if indicated to induce calciuresis
  • IV bisphosphonates (pamidronate, zoledronate)
  • Calcitonin
  • Glucocorticoids
  • Dialysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

____ is the most common outpatient cause of hypercalcemia

A

Primary hyperparathyroidism is the most common outpatient cause of hypercalcemia

  • Commonly in ≥ 50 years old
  • Onset in childhood suggests hereditary disorder such as MEN 1 or 2A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Primary hyperparathyroidism is most commonly caused by ___

A

Primary hyperparathyroidism is most commonly caused by benign solitary parathyroid adenoma

  • 85%: benign solitary parathyroid adenoma
  • 5%: 2 adenomas present
  • 10%: multiple gland hyperplasia (sporadic vs MEN 1 / 2A)
  • Parathyroid malignancy is rare
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe mechanism of primary hyperparathyroidism

A

Primary hyperparathyroidism mechanism

  • Lack of negative feedback from Ca and 1,25 Vitamin D to PTH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Normal to high PTH and high Ca is ___

A

Normal to high PTH and high Ca is hyperparathyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Low PTH and low Ca is ____

A

Low PTH and low Ca is hypoparathyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Low PTH and high Ca is ___

A

Low PTH and high Ca is non-PTH hypercalcemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe lab features of primary hyperparathyroidism

A

Primary hyperparathyroidism lab features

  • High serum Ca with normal to elevated PTH
  • Often low phosphorus levels present
  • High / normal urine Ca: high serum Ca spills over into urine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Primary hyperparathyroidisim renal manifestations include ____ and ____

A

Primary hyperparathyroidisim renal manifestations include polyuria and nephrolithiasis / nephrocalcinosis

  • Nephrolithiasis / nephrocalcinosis especially if 24 hr urine Ca > 300 mg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe bone manifestations of primary hyperparathyroidism

A

Primary hyperparathyroidism bone manifestations

  • Osteoporosis / fractures / low bone mineral density
  • Leads to more cortical bone loss (forearm) over trabecular
  • Severe manifestations (osteitis fibrosa cystica) are rare: periosteal resorption in distal phalanges, bone cysts / brown tumors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Salt and pepper skull occurs in ____

A

Salt and pepper skull occurs in Salt and pepper skull occurs in hyperparathyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe primary hyperparathyroidism treatment

A

Primary hyperparathyroidism treatment

  • If asymptomatic: observe
  • If symptomatic and / or progression likely: surgery
  • Calcimimetics (cinacalcet): lower serum Ca by decreasing PTH secretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Calcimimetics (cinacalcet) lower serum Ca by ____

A

Calcimimetics (cinacalcet) lower serum Ca by decreasing PTH secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Both primary hyperparathyroidism and familial hypocalciuric hypercalcemia have ____ and ____

A

Both primary hyperparathyroidism and familial hypocalciuric hypercalcemia have high serum Ca and normal to elevated PTH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe familial hypocalciuric hypercalcemia

A

Familial hypocalciuric hypercalcemia

  • Autosomal dominant
  • One allele of CaSR inactivated
  • Hypercalcemia is mild
  • Hypocalciuria
  • PTH slightly elevated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe neonatal severe hyperparathyroidism

A

Neonatal severe hyperparathyroidism

  • Autosomal recessive
  • Both CaSR alleles inactivated
  • Severe hypercalcemia
  • Hypocalciuria
  • PTH elevated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Fractional excretion of Ca: FeCa = ____

A

Fractional excretion of Ca: FeCa = [(UCa x PCr) / (UCr x PCa)] x 100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

FeCa ____ in familial hypocalciuric hypercalcemia

A

FeCa < 1% in familial hypocalciuric hypercalcemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Look for ___ in familial hypocalciuric hypercalcemia

A

Look for low urine Ca in familial hypocalciuric hypercalcemia

  • Use 24 hour collection: calculate FeCa
  • FMHx (autosomal dominant): relative with hypercalcemia, hypercalcemia known in infancy
  • Treatment: observation, NO surgery
26
Q

Humoral hypercalcemia mechanisms are ____, ____, and ____

A

Humoral hypercalcemia mechanisms are PTHrP, local bone resorption, and ectopic Vitamin D

27
Q

Describe PTHrP mechanism of humoral hypercalcemia of malignancy

A

PTHrP mechanism of humoral hypercalcemia of malignancy

  • PTh related peptide: factor primarily involved with chondrocyte replication at the growth plate
  • Binds to PTH receptor
  • Highly expressed in fetus and breast milk
  • Commonly produced by squamous cell carcinoma of lung / neck / head and carcinoma of kidney and ovary

Measure PTHrP

28
Q

Describe local bone resorption mechanism of humoral hypercalcemia of malignancy

A

Local bone resorption mechanism of humoral hypercalcemia of malignancy

  • Via tumor cell production of osteolytic factors
  • Multiple myeloma, breast cancer, prostate cancer, lymphoma

Check imaging (bone scan, X-rays)

29
Q

Describe ectopic Vitamin D mechanism of humoral hypercalcemia of malignancy

A

Ectopic Vitamin D mechanism of humoral hypercalcemia of malignancy

  • Ectopic Vitamin D 1,25-(OH)2 production: due to ectopic production of 1-alpha-hydroxylase, leukomia / lymphoma / renal cell cancer / granulomatous disease (TB, sarcoidosis)

Measure Vitamin D 1,25-(OH)2 level

30
Q

Evaluation for humoral hypercalcemia of malignancy includes ____, ____, and ____

A

Evaluation for humoral hypercalcemia of malignancy includes measuring PTHrP, checking imaging (bone scan / X-rays), and Vitamin D 1,25-(OH)2 production

31
Q

Describe the diagnostic algorithm for hypercalcemia

A

Diagnostic algorithm for hypercalcemia

32
Q

Most commonly a low reported Ca is ___

A

Most commonly a low reported Ca is NOT true hypocalcemia

33
Q

Correct serum Ca for ____

A

Correct serum Ca for albumin < 4.0 mg / dL

  • Serum Ca is bound to circulating proteins: 40% bound to albumin and other proteins
  • Low albumin leads to low total serum Ca measurement but the free (ionized) Ca is normal
34
Q

Corrected Ca = _____

A

Corrected Ca = total measured Ca + [(4 - albumin) x 0.8]

  • Add 0.8 to the total measured Ca for every 1 point the albumin is below 4
35
Q

Describe clinical features of hypocalcemia

A

Hypocalcemia clinical features

  • Neuromuscular irritability
  • Paresthesias
  • Chvostek’s / Trousseai’s signs
  • Laryngospasm
  • Bronchospasm
  • Prolonged QT interval
  • Seizures
  • Tetany
36
Q

Hypoparathyroidism can be ____, ____, or ____

A

Hypoparathyroidism can be destruction, congenital, or functional

  • Destruction: surgical, autoimmune, destruction by ionizing radiation / infiltration
  • Congenital (abnormal development): DiGeorge, velo-cardio-fascial syndrome
  • Functional: hypomagnesemia (PTH secretion is dependent on Mg)
37
Q

Describe hypocalcemia in renal failure

A

Hypocalcemia in renal failure

  • Loss of renal responsiveness to PTH results in increased urinary Ca loss and decreased P excretion: develop secondary hyperparathyroidism
  • Hyperphosphatemia reduces Ca solubility
  • Reduced 1-alpha hydroxylase activity with reduced 1,25-(OH)2 Vitamin D production
38
Q

Loss of renal responsiveness to PTH results in ____ urinary Ca loss and ____ P excretion

A

Loss of renal responsiveness to PTH results in increased urinary Ca loss and decreased P excretion

39
Q

Describe treatment for hypocalcemia

A

Hypocalcemia treatment

  • Ca (IV, oral)
  • Vitamin D
  • Calcitriol (Vitamin 1,25 D): in hypoparathyroidism, Vitamin D resistant rickets, renal failure
  • Parathyroid hormone (Natpara)
40
Q

Describe diagnostic algorithm for hypocalcemia

A

Hypocalcemia diagnostic algorithm

41
Q

Rickets / osteomalacia are ____ due to ____, ____, or ____

A

Rickets / osteomalacia are defect in bone mineralization due to Vitamin D deficiency, Ca deficiency, and P deficiency

  • P deficiency: malabsorption, phosphorus wasting conditions
42
Q

Describe pathogenesis of Vitamin D deficiency in rickets and osteomalacia

A

Vitamin D deficiency in rickets and osteomalacia

  1. Chronic low Vitamin D
  2. Decrease in Ca absorption from gut
  3. Decrease in serum Ca and increase in PTH (secondary hyperparathyroidism)
  4. Increased urinary Ca reabsorpion and PO4 excretion
  5. Increased bone resorption

Serum Ca is preserved at expense of bone

Hypocalcemia and hypophosphatemia present only if severe long-standing Vitamin D deficiency

43
Q

In Vitamin D deficiency causing rickets and osteomalacia, ____ is preserved at expense of bone

A

In Vitamin D deficiency causing rickets and osteomalacia, serum Ca is preserved at expense of bone

44
Q

Rickets / osteomalacia clinical features are ____, ____, and ____

A

Rickets / osteomalacia clinical features are skeletal deformities, bone pain / fragility / fractures, and muscular hypotonia / weakness

  • Bone pain, fragility, fractures: effect of secondary hyperparathyroidism
45
Q

Descibe Vitamin D sources

A

Vitamin D sources

  • Sun: need UVB rays to make Vitamin D
  • Diet
  • Limitations: where you live, body surface exposure, sunscreen, skin cancer risk, naturally dark skin tone, older age (less efficient at making Vitamin D)
46
Q

Describe major causes of Vitamin D deficiency

A

Vitamin D deficiency causes

  • lack of intake exposure
  • Decreased skin synthesis
  • Decreased bioavailability: intestinal malabsorption (Celiac), obesity
  • Increased intestinal losses
47
Q

Vitamin D 25-OH represents the ____ and should be measured to ____

A

Vitamin D 25-OH represents the storage form and should be measured to diagnose Vitamin D deficiency

48
Q

Vitamin D 1,25-(OH)2 is the ____ form

A

Vitamin D 1,25-(OH)2 is the active form

  • Due to secondary hyperparathyroidism: Vitamin D converted to this form
  • Body tries to maintain this level in the normal range as much as possible
49
Q

Describe treatment of rickets / osteomalacia

A

Rickets / osteomalacia

  • Vitamin D2 (ergocalciferol): prescription
  • Vitamin D (cholecalciferol): over the counter
  • Ca: diet / supplements
  • Calcitriol (Vitamin D 1,25(OH)2) if indicated: prescription
  • Phosphate (if indicated)
50
Q

Osteoporosis is ___

A

Osteoporosis is compromised bone strength prediposing to increased risk of fracture

  • Bone strength: bone density and bone quality
51
Q

Osteoporosis is T-score ____

A

Osteoporosis is T-score ≤ -2.5

(DXA)

(osteopenia is -2.5 < x < 1)

52
Q

Describe pathogenesis of osteoporosis

A

Pathogenesis of osteoporosis

  • Resorption > formation, increased bone loss, low peak bone mass
  • Poor bone quality, low bone density, propensity to fall
53
Q

Peak bone mass is ____

A

Peak bone mass is maximum bone mass or density achieved during a lifetime

  • Strongest predictor of BMD in old age is BMD at younger age
  • Skeletal sites reach maturity at different ages
54
Q

___ is used to measure bone strength

A

DXA is used to measure bone strength

  • T-score: SD compared to young adults
  • Z-score: SD compared to age/sex-matched controls
55
Q

As age increases, bone density ____ and fracture risk ____

A

As age increases, bone density decreases and fracture risk increases

56
Q

Describe osteoporosis prevention

A

Osteoporosis prevention

  • Maximize peal bone density achieved in adolescence: physical activity, adequate Ca and Vitamin D
  • Minimize other causes: amenorrhea / hypogonadism, tobacco, alcohol, medications, eating disorders
  • Health lifestyle interventions possible at any age
57
Q

Antiresorptive osteoporosis therapy consists of ____, ____, ____, ____, and ____

A

Antiresorptive osteoporosis therapy consists of bisphosphonates, denosumab, selective estrogen receptor modulators, estrogen, and calcitonin

(post-menopausal women, men ≥ 50 years old)

58
Q

Anabolic therapy for osteoporosis includes ____, ____, and ____

A

Anabolic therapy for osteoporosis includes teriparatide, abaloparatide, and romosozumab

(postmenopausal women, men ≥ 50 years old)

59
Q

Paget’s disease is ____ caused by ____

A

Paget’s disease is hyperdynamic bone remodeling caused by increased osteoclast and osteoblast activity

  • Etiology: viral (paramyxovirus)
  • Often asymptomatic
  • Detection by elevated alkaline phosphattase or incidental radiologic exam
60
Q

Severity of Paget’s disease correlates with ___

A

Severity of Paget’s disease correlates with rise in alkaline phosphatase level

  • Alkaline phosphatase is not specific to bone: osteoblasts, liver or intestine
  • If of bone origin: represents any state of high bone turnover
61
Q

Describe clinical features of Paget’s disease

A

Paget’s disease clinical features

  • Characteristic features on radiograph and bone scan
  • Degenerative changes: pain, nerve compression / entrapment, hearing loss
  • Labs: normal serum Ca, normal P, normal PTH, high alkaline phosphatase
  • Bony deformities
  • Pathologic fracture with minimal trauma
  • Increased bone vascularity: high output CHF
  • Small risk of osteosarcoma development
62
Q

Paget’s Disease therapy involves ___

A

Paget’s Disease therapy involves treatment to relieve symptoms and prevent complications

  • NSAIDs / PT for pain
  • Bisphosphonate therapy: cyclic oral or IV therapy highly effective in normalizing alkaline phosphatase levels and diminishing disease progression
  • Calcitonin shown to decrease disease progression